Perceptive Advisors LLC Legend Biotech Corp Transaction History

Perceptive Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$33.54 - $55.0 $20.7 Million - $33.9 Million	-616,141 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$31.02 - $48.18 $13.2 Million - $20.6 Million	427,041 Added 225.83%	616,141 $22.4 Million
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $7.78 Million - $10.8 Million	189,100 New	189,100 $8.81 Million
Q1 2021 May 17, 2021	SELL	$23.55 - $32.4 $588,750 - $810,000	-25,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$36.1 - $42.56 $902,500 - $1.06 Million	25,000 New	25,000 $1.06 Million

198

74.2M

374K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $8.5B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.